U.S. Pharma Stock News

The Morning Bull - US Market Morning Update Wednesday, Apr, 8 2026 US stock futures are pointing higher this morning, with E-mini S&P 500 contracts up about 2.6% and Nasdaq-100 futures roughly 3.4% firmer, as a ceasefire push in the Middle East pulls the VIX volatility gauge down around 12%. Government bond yields are reacting too, with the US 10 year near 4.25% while markets wait for Friday’s CPI, a key scorecard for the pace of price increases. Lower volatility and easier bond markets tend...

Worthington Steel, Inc. has reported its third-quarter and nine-month results to February 28, 2026, with sales rising to US$769.8 million and US$2.51 billion respectively, while quarterly net income and earnings per share eased compared with the prior year, and the board declared a US$0.16 quarterly dividend payable June 26, 2026. An interesting contrast emerges as nine-month net income increased to US$66.0 million year on year even though third-quarter earnings and per-share results...

Those following along with Precision Optics Corporation, Inc. ( NASDAQ:POCI ) will no doubt be intrigued by the recent...

Investors who take an interest in Peapack-Gladstone Financial Corporation ( NASDAQ:PGC ) should definitely note that...

We wouldn't blame Sinclair, Inc. ( NASDAQ:SBGI ) shareholders if they were a little worried about the fact that Daniel...

We'd be surprised if Oil States International, Inc. ( NYSE:OIS ) shareholders haven't noticed that the Independent...

Even if it's not a huge purchase, we think it was good to see that Brian Roney, the President & CEO of Presurance...

FitLife Brands, Inc.'s ( NASDAQ:FTLF ) earnings announcement last week didn't impress shareholders. However, our...

Even if it's not a huge purchase, we think it was good to see that Junhua Wu, the Co-Founder of Baozun Inc...

If you are wondering whether Universal Technical Institute at around US$36.29 is priced for opportunity or already reflects the story you are buying into, this article walks through what the current valuation is actually indicating. The stock has returned 0.5% over the last 7 days, 3.7% over the last 30 days and 46.1% year to date, with a 39.1% return over the last year and a very large gain over 5 years. Recent coverage around Universal Technical Institute has focused on its role in the...

Wondering whether U-Haul Holding is a bargain or a value trap at around US$48.76? This breakdown will help you size up the stock with a clear valuation lens. The share price has moved 2.1% over the last 7 days, while returns sit at a 2.2% decline over 30 days and a 3.5% decline year to date, with a 16.9% decline over the past year and 19.9% and 20.4% declines across the 3 and 5 year periods respectively. Recent coverage has focused on U-Haul Holding as a long established name in do it...

Investors may be wondering whether Ituran Location and Control is still priced attractively after a strong run, or if most of the easy gains are already on the table. The stock last closed at US$51.48, with returns of 5.0% over 7 days, 3.9% over 30 days, 21.1% year to date, 74.1% over 1 year, 179.8% over 3 years and 192.4% over 5 years. This performance may have changed how investors are thinking about risk and reward. Recent company news has kept Ituran Location and Control in focus for...

Dorman Products (NasdaqGS:DORM) has appointed President and CEO Kevin Olsen as Chairman of the Board. Former Chairman Steven Berman will remain on the board following this leadership change. The move combines the CEO and Chairman roles, signaling a new governance structure for the company. Dorman Products, which focuses on replacement parts for the automotive aftermarket, now has Kevin Olsen serving as President, CEO and Chairman. For investors, this kind of leadership consolidation can...

Giftify’s CardCash will be integrated into Capital One Shopping, reaching tens of millions of users.

Regulatory milestone for lorundrostat Mineralys Therapeutics (MLYS) recently reported that the FDA accepted its New Drug Application for lorundrostat in hypertension, while also updating investors on the Explore OSA trial in obstructive sleep apnea. See our latest analysis for Mineralys Therapeutics. Mineralys Therapeutics’ share price has pulled back over the past quarter, with a 90 day share price return of 19.92% decline and year to date return of 20.72% decline. However, the 1 year total...

Artificial intelligence in healthcare is one of the clearest ways technology meets real world need, especially as higher energy prices, geopolitical tension, and sticky inflation keep pressure on costs and productivity. While many sectors face softer activity and rising input prices, AI tools that support better diagnostics, smoother hospital operations, and faster drug discovery speak directly to efficiency and outcomes. This screener focuses on companies applying AI to these problems,...

If you are trying to work out whether Credit Acceptance at around US$444 per share looks expensive or offers value, the starting point is understanding what the current share price actually reflects. Over the last week the stock is up 5.0%, while the 1 year return sits at a 5.0% decline and the year to date move is a 2.0% decline, which hints that sentiment around risk and reward has shifted more than once recently. The share price moves sit against a backdrop of ongoing attention on...

If you are wondering whether Clearway Energy's share price still offers value after a strong run, the key is understanding what the current market price might already be factoring in. The stock last closed at US$39.64, with returns of 1.2% over 7 days, 12.7% over 30 days, 23.4% year to date, 68.3% over 1 year, 58.3% over 3 years and 94.3% over 5 years. This raises the question of how much of the story is already reflected in the valuation. Recent news around Clearway Energy has focused on...

In its latest results, WillScot Holdings reported a 13% year-over-year decline in EBITDA, a similar drop in units on rent, and wrote off about 15% of its rental fleet, underscoring mounting financial and operational pressure. These fleet impairments and signs of tougher competition, particularly from United Rentals, point to a business mix tilting toward smaller, less profitable segments. Against this backdrop of fleet write-offs and weakening core metrics, we will assess how the news...

Why Brookfield Wealth Solutions is on investors’ radar today Brookfield Wealth Solutions (BNT) has been drawing attention after a period where the share price shows mixed returns across different time frames. This has prompted closer scrutiny of its business mix and current valuation. See our latest analysis for Brookfield Wealth Solutions. The latest 1 day share price return of a 0.4% decline and 90 day share price return of a 12% decline contrast with a 1 year total shareholder return of...

Wondering whether Vera Therapeutics at around US$40.45 is still offering value, or if the easy gains are behind it? This article is designed to help you frame that question clearly. The stock has returned 6.2% over the last week and 3.5% over the last month, while year to date it is down 16.8% but up 102.8% over the past year and a very large amount over three years. This naturally raises questions about what is already priced in. Recent coverage has focused on Vera Therapeutics as investors...

Some AnaptysBio, Inc. ( NASDAQ:ANAB ) shareholders may be a little concerned to see that the Independent Director, John...

Check Point Software Technologies Ltd. ( NASDAQ:CHKP ) just reported some strong earnings, and the market reacted...

If you are wondering whether Louisiana-Pacific at around US$72 a share is offering good value or is already pricing in a lot of expectations, this article will help you frame that question using several valuation lenses. The stock has been choppy recently, with a 2.6% gain over the last 7 days, a 7.2% decline over 30 days, and year-to-date returns showing an 11.7% decline, while the 3-year and 5-year returns sit at 35.5% and 22.4% respectively. Recent attention on Louisiana-Pacific has...